PARP inhibitors such as Olaparib and Veliparib proved to be neuroprotective in an in vitro model of cortical projection neurons death induced by different excitotoxic stimuli [50] and in an in vivo model of transient cerebral ischemia [51]. This evidence concerns the gene PARP1 and transient ischemic attack.